| Literature DB >> 35145588 |
Emmanuel Kobina Mesi Edzie1,2, Klenam Dzefi-Tettey3, Edmund Kwakye Brakohiapa4, Philip Narteh Gorleku1, Eric Aidoo5, Kwasi Agyen-Mensah6, Peter Appiah-Thompson7, Adu Tutu Amankwa8, Ewurama Andam Idun9, Frank Quarshie10, Richard Ato Edzie1, Benard Osei10, Prosper Dziwornu1, Abdul Raman Asemah1.
Abstract
INTRODUCTION: spontaneous acute intracranial hemorrhage (SICH) accounts for approximately 10-15% of all stroke cases. Early detection by computed tomography (CT) and early treatment are key. Hence this study to examine the CT features of SICH.Entities:
Keywords: Computed tomography; Ghana; features; spontaneous acute intracranial hemorrhages
Mesh:
Year: 2021 PMID: 35145588 PMCID: PMC8797039 DOI: 10.11604/pamj.2021.40.226.31934
Source DB: PubMed Journal: Pan Afr Med J
socio-demographics of participants
| Variable | Count/frequency | Percentage (%) |
|---|---|---|
|
| ||
| Minimum | 15 years | |
| Maximum | 100 years | |
| Mean (SD) | 61.25 (17.25) years | |
|
| ||
| <20 years | 2 | 0.46% |
| 20-40 years | 61 | 14.02% |
| 41-60 years | 125 | 28.74% |
| >60 years | 247 | 56.78% |
|
| ||
| Males | 224 | 51.49% |
| Females | 211 | 48.51% |
Figure 1risk factors of intracranial hemorrhage
distribution of the risk factors among age and sex
| Variable | Age group | P-value | |||
|---|---|---|---|---|---|
| Risk factors | <20years | 20-40 years | 41-60years | >60years | |
| Anticoagulants | - | 5(16.13%) | 11(35.48%) | 15(48.39%) | 0.752 |
| Smoking | - | 3(6.52%) | 20(42.48%) | 23(50.00%) | 0.086 |
| DM-2 | 2(0.82%) | 45(18.37%) | 61(24.90%) | 137(55.92%) | 0.007* |
| Dyslipidemia | - | 33(12.84%) | 82(31.91%) | 142(55.25%) | 0.113 |
| Hypertension | 2(0.53%) | 48(12.83%) | 114(30.48%) | 210(56.15%) | 0.110 |
|
| |||||
|
|
| ||||
| Anticoagulants | 21(67.74%) | 10(32.26%) | 0.060 | ||
| Smoking | 45(97.83%) | 1(2.17%) | <0.001* | ||
| DM-2 | 147(60.00%) | 98(40.00%) | <0.001* | ||
| Dyslipidemia | 125(48.64%) | 132(51.36%) | 0.152 | ||
| Hypertension | 196(52.41%) | 178(47.59%) | 0.346 | ||
Statistically significant
Figure 2proportions of the subtypes of intracranial hemorrhage
distribution of the intracranial hemorrhage types among sex and age group
| Sex | Intracerebral hemorrhage | Epidural hemorrhage | Subdural hemorrhage | Subarachnoid hemorrhage | P-value |
|---|---|---|---|---|---|
| Males | 219 (51.41%) | 2 (100.00%) | 1 (50.00%) | 2 (40.00%) | 0.542 |
| Females | 207 (48.59%) | - | 1 (50.00%) | 3 (60.00%) | |
|
| |||||
| <20 years | 1 (0.23%) | - | 1 (50.00%) | - | <0.001* |
| 20-40 years | 57 (13.38%) | - | 1 (50.00%) | 3 (60.00%) | |
| 41-60 years | 122 (28.64%) | 1 (50.00%) | - | 2 (40.00% | |
| >60 years | 246 (57.75%) | 1 (50.00%) | - | - | |
*Statistically significant
Figure 3an axial non-enhanced CT scan of the head showing an acute right frontal intraparenchymal hemorrhage (red arrow), perilesional edema without a midline shift (blue short arrows), and subtle acute left occipital epidural hematoma (yellow short arrows)
Figure 4a non-contrast axial CT scan of the head showing an acute right basal ganglia hemorrhage (red arrow), perilesional edema (blue short arrows), extension into the ipsilateral lateral ventricle (yellow arrow) and mass effect (green arrow)
Figure 5an axial non-enhanced CT scan of the brain showing hyperdense collections of acute bleed in both thalami (red arrows) and extension into the lateral ventricles (yellow arrows)
Figure 6a non-contrast head CT scan showing acute subdural hematomas with loss of gyri and sulci (red short and violet arrows), mass effect (green short arrows), midline shift (yellow arrow) compared to the normal midline position (yellow short arrow)
proportions of CT scan features/patterns for intracerebral and subdural hemorrhages
| Proportions of CT scan features for intracerebral hemorrhage (n=426) | ||
|---|---|---|
| Count | Percentage | |
| Hyperdense lesion extending to the edge of the brain | 204 | 25.03% |
| Hyperdense lesion with perilesional hypodensity/edema | 334 | 40.98% |
| Hyperdense lesion with mass effects/mid-line shift to the opposite side | 185 | 22.70% |
| Hyperdense lesion with extension into ventricular systems | 79 | 9.69% |
| Small hyperdensity deep in the brain/petechiae | 13 | 1.60% |
|
| 815 | 100.00% |
|
| ||
| Hyperdense crescentic lesion between the brain and the skull | 2 | 25.00% |
| Crosses suture lines but never crosses dural reflections | 2 | 25.00% |
| Hyperdense crescentic lesion with mass effects/mid-line shift to the opposite side | 2 | 25.00% |
| Loss of gyri and sulci prominence | 2 | 25.00% |
|
| 8 | 100.00% |
Figure 7an axial non-enhanced CT scan of the head showing hyperdense collections of acute blood attenuation in the sulci in keeping with acute subarachnoid hemorrhage (blue short arrows)
proportions of CT scan features/patterns for epidural and subarachnoid hemorrhages
| Proportions of CT scan features for epidural hemorrhage (n=2) | ||
|---|---|---|
| Count | Percentage | |
| Hyperdense biconvex lens-shaped lesion between the brain and skull | 2 | 25.00% |
| Does not cross suture lines but may cross dural reflections | 2 | 25.00% |
| Hyperdense lesion with mass effects/mid-line shift to the opposite side | 2 | 25.00% |
| Loss of gyri and sulci prominence | 2 | 25.00% |
|
| 8 | 100.00% |
|
| ||
| Hyperdense cerebrospinal fluid instead of its usual hypodense appearance | 5 | 33.33% |
| Hyperdensities in the external cerebrospinal fluid spaces | 5 | 33.33% |
| Intraventricular hyperdensities especially in the occipital Horns of the lateral ventricles | 5 | 33.33% |
|
| 15 | 100.00% |
logistic regression analysis
| Risk factors | Odd ratio (OR) | 95% confidence interval (CI) | P-Value |
|---|---|---|---|
|
| |||
| Anticoagulants | 0.88 | 0.41-1.89 | 0.739 |
| Smoking | 0.23 | 0.11-0.47 | <0.001* |
| Type 2 diabetes mellitus | 1.25 | 0.79-1.99 | 0.339. |
| Dyslipidemia | 0.90 | 0.56-1.43 | 0.649 |
| Hypertension | 0.80 | 0.45-1.41 | 0.438 |
|
| |||
| Anticoagulants | 2.56 | 1.15-5.72 | 0.022* |
| Smoking | 2.24 | 1.14-4.41 | 0.019* |
| Type 2 diabetes mellitus | 0.77 | 0.45-1.33 | 0.352 |
| Dyslipidemia | 0.88 | 0.51-1.50 | 0.628 |
| Hypertension | 1.86 | 0.86-4.02 | 0.112 |
|
| |||
| Anticoagulants | 1.38 | 0.63-3.03 | 0.419 |
| Smoking | 1.49 | 0.78-2.86 | 0.230 |
| Type 2 diabetes mellitus | 0.84 | 0.53-1.33 | 0.454 |
| Dyslipidemia | 1.34 | 0.85-2.13 | 0.206 |
| Hypertension | 0.80 | 0.45-1.42 | 0.450 |
|
| |||
| Anticoagulants | 1.91 | 0.55-6.68 | 0.309 |
| Smoking | 13.22 | 1.76-99.24 | 0.012* |
| Type 2 diabetes mellitus | 0.77 | 0.42-1.40 | 0.386 |
| Dyslipidemia | 1.87 | 1.02-3.42 | 0.042* |
| Hypertension | 0.94 | 0.46-1.90 | 0.854 |
*Statistically significant